Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase - Application in a Brown Norway rat model of allergic pulmonary inflammation

被引:123
作者
Schneider, T [1 ]
Issekutz, AC [1 ]
机构
[1] DALHOUSIE UNIV,DEPT PEDIAT & MICROBIOL IMMUNOL,HALIFAX,NS,CANADA
关键词
asthma; hypersensitivity; airway; leukocyte recruitment; animal model; allergy; INDUCED AIRWAY HYPERRESPONSIVENESS; POLYMORPHONUCLEAR LEUKOCYTES; ANTIGEN CHALLENGE; GUINEA-PIGS; ACCUMULATION; EXPRESSION; RESPONSES; ASTHMA; CD11B;
D O I
10.1016/0022-1759(96)00143-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Conditions for measuring selectively eosinophil peroxidase (EPO) and the neutrophil myeloperoxidase (MPO) in inflamed rat lung were determined. EPO could be specifically measured with o-phenylene diamine as chromogen at pH 8.0 in the presence of 3 mM bromide and MPO with tetramethylbenzidine as chromogen at pH 5.0 in the absence of bromide but with the EPO inhibitor, resorcinol. Aeroallergen challenge of sensitized Brown Norway rats with ovalbumin, but not with saline, resulted in a pronounced eosinophilic lung inflammation with some focal hemorrhages and an increase in lung wet weights. Quantitation of the eosinophil and neutrophil accumulation required lyophilization of lung samples, a hypotonic wash to remove contaminating hemoglobin, which interfered with the MPO assay, followed by extraction with the detergent cetyltrimethylammonium chloride. Based on lung EPO and MPO activities and standardization of enzyme activity with purified eosinophils and neutrophils, the total number of eosinophils and neutrophils in the lungs was calculated at 24 h (n = 19), 48 h (n = 9) and 72 h (n = 4) after challenge, as 56 +/- 6.4 x 10(6), 119 +/- 28 x 10(6) and 108 +/- 33 x 10(6) for eosinophils, respectively, and 94 +/- 6.8 x 10(6), 49 +/- 5.0 x 10(6) and 32 +/- 5.5 x 10(6) for neutrophils, respectively. We conclude that, with the assay conditions outlined here, EPO and MPO can be used to quantitate the tissue infiltration of eosinophils and neutrophils in the rat even in mixed inflammatory reactions.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 38 条
[1]   CELLULAR MARKERS OF INFLAMMATION IN THE AIRWAYS OF ALLERGIC SHEEP WITH AND WITHOUT ALLERGEN-INDUCED LATE RESPONSES [J].
ABRAHAM, WM ;
SIELCZAK, MW ;
WANNER, A ;
PERRUCHOUD, AP ;
BLINDER, L ;
STEVENSON, JS ;
AHMED, A ;
YERGER, LD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (06) :1565-1571
[2]   QUANTITATIVE-DETERMINATION OF MYELOPEROXIDASE USING TETRAMETHYLBENZIDINE AS SUBSTRATE [J].
ANDREWS, PC ;
KRINSKY, NI .
ANALYTICAL BIOCHEMISTRY, 1982, 127 (02) :346-350
[3]   STUDIES ON RAT EOSINOPHIL PEROXIDASE [J].
ARCHER, GT ;
AIR, G ;
JACKAS, M ;
MORELL, DB .
BIOCHIMICA ET BIOPHYSICA ACTA, 1965, 99 (01) :96-&
[4]   INDUCTION OF LOW-DENSITY AND UP-REGULATION OF CD11B EXPRESSION OF NEUTROPHILS AND EOSINOPHILS BY DEXTRAN SEDIMENTATION AND CENTRIFUGATION [J].
BERENDS, C ;
DIJKHUIZEN, B ;
DEMONCHY, JGR ;
GERRITSEN, J ;
KAUFFMAN, HF .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 167 (1-2) :183-193
[5]   SOME PROPERTIES OF HUMAN EOSINOPHIL PEROXIDASE, A COMPARISON WITH OTHER PEROXIDASES [J].
BOLSCHER, BGJM ;
PLAT, H ;
WEVER, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 784 (2-3) :177-186
[6]   SOME ENZYMATIC CHARACTERISTICS OF EOSINOPHIL PEROXIDASE FROM PATIENTS WITH EOSINOPHILIA AND FROM HEALTHY DONORS [J].
BOS, AJ ;
WEVER, R ;
HAMERS, MN ;
ROOS, D .
INFECTION AND IMMUNITY, 1981, 32 (02) :427-431
[7]   ASSAY OF THE HUMAN-LEUKOCYTE ENZYMES MYELOPEROXIDASE AND EOSINOPHIL PEROXIDASE [J].
BOZEMAN, PM ;
LEARN, DB ;
THOMAS, EL .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 126 (01) :125-133
[8]   MECHANISMS OF INFLAMMATION IN THE ASTHMATIC PATIENT [J].
BUSSE, WW .
ALLERGY PROCEEDINGS, 1993, 14 (01) :5-8
[9]   A SIMPLE RELIABLE ASSAY FOR MYELOPEROXIDASE ACTIVITY IN MIXED NEUTROPHIL-EOSINOPHIL CELL-SUSPENSIONS - APPLICATION TO DETECTION OF MYELOPEROXIDASE DEFICIENCY [J].
CRAMER, R ;
SORANZO, MR ;
DRI, P ;
MENEGAZZI, R ;
PITOTTI, A ;
ZABUCCHI, G ;
PATRIARCA, P .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 70 (01) :119-125
[10]  
CRAMER R, 1980, ADV EXP MED A, V121, P91